Solid Tumors of the Body and Tail of the Pancreas

Surgical Clinics of North America

Volumn 90, Issue 2, 2010, Pages 287-307

  Morgan, Katherine A ^a   Adams, David B ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Laparoscopic surgery; Neuroendocrine tumors; Pancreatic adenocarcinoma; Surgical resection

Indexed keywords

OCTREOTIDE; PREDNISOLONE;

ANAMNESIS; AUTOIMMUNE PANCREATITIS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG DOSE REDUCTION; DRUG MEGADOSE; ENDOSCOPIC ECHOGRAPHY; HUMAN; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SKILL; SOLID TUMOR; SURGEON; TREATMENT PLANNING;

ADENOCARCINOMA; AUTOIMMUNE DISEASES; CARCINOMA, NEUROENDOCRINE; DISEASE-FREE SURVIVAL; ENDOSONOGRAPHY; GASTRINOMA; GLUCAGONOMA; HUMANS; INSULINOMA; LAPAROSCOPY; MAGNETIC RESONANCE IMAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATITIS; PROGNOSIS; SOMATOSTATINOMA; TOMOGRAPHY, X-RAY COMPUTED; VIPOMA;

EID: 77950829872     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2009.12.009     Document Type: Review

References (125)

1. Bipat S., Phoa S.S., van Zeldan O.M. Ultrasonography, computed tomography, and magnetic resonance imaging for diagnosis and determining respectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr 2005, 29:438-445.
2. Anderson M.A., Carpenter S., Thompson N.W., et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 2000, 95:2271.
3. Omar S., Seewald S., Seitz U., et al. Reliability of EUS in exclusion of pancreatic cancer-results of the Hamburg-Eppendorf study. Endoscopy 2006, 38S2:A35.
4. Maguchi H., Takahashi K., Osanai M., et al. Small pancreatic lesions is there need for EUS-FNA preoperatively? What to do with the incidental lesions?. Endoscopy 2006, 38S1:S53-S56.
5. Chang K.J. Endoscopic ultrasound and FNA in pancreaticobiliary tumors. Endoscopy 2006, 38S1:S56-S60.
6. Papanikolaou I.S., Adler A., Neumann U., et al. Endoscopic ultrasound in pancreatic disease-its influence on surgical decision making. Pancreatology 2009, 9:55-65.
7. Bournet B., Migueres I., Delacroix M., et al. Early morbidity of endoscopic ultrasound: 13 years experience at a referral center. Endoscopy 2006, 38:349-354.
8. Gress F.G., Hawes R.H., Savides T.H., et al. Role of EUS in the preoperative staging of pancreatic cancer: a large single center experience. Gastrointest Endosc 1999, 50:786-791.
9. Yovino S., Darwin P., Daly B., et al. Predicting unresectability in pancreatic cancer patients: the additive effects of CT and endoscopic ultrasound. J Gastrointest Surg 2007, 11:36-42.
10. Ferrone C.R., Warshaw A.L., Rattner D.W., et al. Pancreatic fistula rates after 462 distal pancreatectomies: staplers do not decrease fistula rate. J Gastrointest Surg 2008, 12:1691-1697.
11. Warshaw A.L. Conservation of the spleen with distal pancreatectomy. Arch Surg 1988, 123:550-553.
12. Richardson D.Q., Scott Connor L.E.H. Distal pancreatectomy with and without splenectomy, a comparison study. Am Surg 1989, 55:21-25.
13. Fahy B.N., Frey C.F., Ho H.S., et al. Morbidity, mortality, and technical factors of distal pancreatectomy. Am J Surg 2002, 183:237-241.
14. Lillimoe K.D., Kaushal S., Cameron J.L., et al. Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg 1999, 229:693-698.
15. Johnson C.D., Flechtmacker J., Trede M. Resection for adenocarcinoma of the body and tail of the pancreas. Br J Surg 1993, 80:1177-1179.
16. Shoup M., Conlon K.C., Klimstra D., et al. Is extended resection for adenocarcinoma of the body and tail of the pancreas justified?. J Gastrointest Surg 2003, 7:946-952.
17. Dalton R.R., Sarr M.G., van Heerden J.A., et al. Cancer of the body and tail of the pancreas: is curative resection justified?. Surgery 1992, 111:489-494.
18. Nordback I.H., Hruban R., Boitnot J.K., et al. Cancer of the body and tail of the pancreas. Am J Surg 1992, 164:26-31.
19. Brennan M.F., Moccia R.D., Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 1996, 223:506-512.
20. Christein J.D., Kendrick M.L., Iqbal C.W., et al. Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas. J Gastrointest Surg 2005, 9:922-927.
21. Bassi C., Dervenis C., Butturini G., et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005, 138:8-13.
22. Fingerhut A., Veyrie N., Ata T., et al. Use of sealants in pancreatic surgery: critical appraisal of the literature. Dig Surg 2009, 26:7-14.
23. Nathan H., Cameron J.L., Goodwin C.R., et al. Risk factors for pancreatic leak after distal pancreatectomy. Ann Surg 2009, 250:277-281.
24. Bernkeim B.M. Organoscopy: cystoscopy of the abdominal cavity. Ann Surg 1911, 53:764-767.
25. Cuschieri A., Hall A.W., Clark J. Value of laparoscopy in the diagnosis and management of pancreatic carcinoma. Gut 1978, 19:672-677.
26. Warshaw A.L., Tepper J.E., Shipley W.U. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg 1986, 151:76-80.
27. Shoup M., Winston C., Brennan M.F., et al. Is there a role for staging laparoscopy in patients with locally advanced unresectable pancreatic adenocarcinoma. J Gastrointest Surg 2004, 8:1068-1071.
28. Liu R.C., Traverso L.W. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc 2005, 19:638-642.
29. Soper N.J., Brunt L.M., Dunnegan D.L., et al. Laparoscopic distal pancreatectomy in the porcine model. Surg Endosc 1994, 8:57-60.
30. Gagner M., Pomp A., Herrera M.F. Early experience with laparoscopic resections of islet cell tumors. Surgery 1996, 120:1051-1054.
31. Melotti G., Butturini G., Piccoli M., et al. Laparoscopic distal pancreatectomy, results on a consecutive series of 58 patients. Ann Surg 2007, 246:77-82.
32. Kooby D., Gillespie T., Bentrem D., et al. Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg 2008, 248:438-446.
33. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas, 616 patients, results, outcomes and prognostic indicators. J Gastrointest Surg 2000, 4:567-579.
34. Sasson A.R., Hoffman J.P., Ross E.A., et al. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?. J Gastrointest Surg 2002, 6:147-158.
35. Watanabe I., Sasaki S., Konishi M. Onset, symptoms, and tumor location as prognostic factors of pancreatic cancers. Pancreas 2004, 28:160-165.
36. Mansour J.C., Chen H. Pancreatic endocrine tumors. J Surg Res 2004, 120:139-161.
37. Vagefi P.A., Oswaldo R., Deshpande V., et al. Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms. Arch Surg 2007, 142:347-354.
38. Gullo L., Migliori M., Falconi M., et al. Nonfunctioning pancreatic endocrine tumors: a multicenter study. Am J Gastroenterol 2003, 98:2435-2439.
39. Gomez-Rivera G., Stewart A.E., Arnoletti J.P., et al. Surgical treatment of pancreatic endocrine neoplasms. Am J Surg 2007, 193:460-465.
40. Kazanjian K.K., Rever H.A., Hines O.J. Resection of pancreatic neuroendocrine tumors. Arch Surg 2006, 141:765-770.
41. Kent R.B., van Heerden J.A., Weiland L.H. Nonfunctioning islet cell tumors. Ann Surg 1981, 193:185-190.
42. Madeira I., Terris B., Voss M., et al. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 1998, 43:422-427.
43. You D.D., Lee H.G., Paik K.Y., et al. The outcomes after surgical resection in pancreatic endocrine tumors: an institutional experience. Eur J Surg Oncol 2009, 35:728-733.
44. King A.D., Ko G.T., Yeung V.T., et al. Dual phase spiral CT in the detection of small insulinomas of the pancreas. Br J Radiol 1998, 71:20.
45. Chung M.J., Choi B.I., Han J.K., et al. Functioning islet cell tumor of the pancreas. Localization with dynamic spiral CT. Acta Radiol 1997, 38:135.
46. Noone T.C., Hosey J., Firat Z., et al. Imaging and localization of islet cell tumors of the pancreas on CT and MRI. Best Pract Clin Endocrinol Metab 2005, 19:195-211.
47. Theoni R.F., Mueller-Lisse U.G., Chan R., et al. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 2000, 214:483-488.
48. Modlin I.M., Cornelius E., Lawton G.P. Use of an isotopic somatostatin receptor probe to image gut endocrine tumors. Arch Surg 1995, 130:367-371.
49. Gibril F., Jensen R.T. Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumors. Dig Liver Dis 2004, 36:S106-S120.
50. Gibril F., Reynolds J.C., Doppman J.L., et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med 1996, 125:26-34.
51. Rosch T., Lightdale C.J., Botet J.F., et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992, 326:1721-1726.
52. Proye C., Malvaux P., Pattou F., et al. Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery 1998, 124:1134-1139.
53. Pais S.A., McGreevy K., LeBlanc J.K., et al. Utility of EUS-FNA in the diagnosis of pancreatic neuroendocrine tumors: correlation with histopathology in 76 patients. Gastrointest Endosc 2007, 65:AB304.
54. Sundin A., Eriksson B., Bergstrom M., et al. PET in the diagnosis of NE tumors. Ann NY Acad Sci 2004, 1014:246-257.
55. Wilder R.M., Allan F.N., Power M.H., et al. Carcinoma of the islands of the pancreas. Hyperinsulinism and hypoglycemia. JAMA 1927, 89:348-354.
56. Campbell W.R., Graham R.R., Robinson W.L. Islet cell tumors of the pancreas. Am J Med Sci 1939, 198:445-454.
57. Nilfarjan M., Warshaw A.L., Axelrod L., et al. Improved contemporary surgical management of insulinomas: a 25 year experience at the Massachusetts General Hospital. Ann Surg 2008, 247:165-172.
58. Service F.J., McMahon M.M., O'Brien P.C., et al. Functioning insulinoma: incidence, recurrence and longterm survival of patients: a 60 year study. Mayo Clin Proc 1991, 66:711-716.
59. Whipple A.O. Adenomas of the islet cells with hyperinsulinism: a review. Ann Surg 1935, 101:1299.
60. Roland C.L. Surgical approach and perioperative complications determine short term outcomes in patients with insulinoma: results of a bi-institutional study. Ann Surg Oncol 2008, 15:3532.
61. Tseng L.M., Chan J.Y., Won J.G. The role of intraarterial calcium stimulated testing with hepatic venous sampling in the management of occult insulinoma. Ann Surg Oncol 2007, 14:2121-2127.
62. Hashimoto L.A., Walsh R.M. Preoperative localization of insulinoma is not necessary. J Am Coll Surg 1999, 189:368-373.
63. Ravi K., Britton B. Surgical approach to insulinomas: are preoperative localization tests necessary?. Ann R Coll Surg Engl 2007, 89:212-217.
64. Patterson E.J., Gagner M., Salky B. Laparoscopic pancreatic resection: a single institution experience of 19 patients. J Am Coll Surg 2001, 193:281-287.
65. SaCanha A., Beau C., Rault A., et al. Laparoscopic versus open approach for solitary insulinoma. Surg Endosc 2007, 21:103-108.
66. Schindl M., Kadzirek K., Kaserer K., et al. Is the new classification of neuroendocrine pancreatic tumors of clinical help?. World J Surg 2000, 24:1312-1317.
67. Zollinger R.M., Ellison E.H. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955, 142:709-723.
68. Gregory R.A., Tracy H.J. The constitution and properties of two gastrins extracted from hog antral mucosa. Gut 1964, 5:103-114.
69. Roy P., Venzon D.J., Shojamanesh H., et al. Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine 2000, 79:379-411.
70. Ectors N. Pancreatic endocrine tumors. Hepatogastroenterology 1999, 46:679-686.
71. Modlin I.M., Lawton G.P. Duodenal gastrinoma: the solution to the pancreatic paradox. J Clin Gastroenterol 1994, 19:184-191.
72. Norton J.A., Fraker D.J., Alexander H.R., et al. Surgery to cure the Zollinger Ellison syndrome. N Engl J Med 1999, 341:635-644.
73. Norton J.A., Fraker D.J., Alexander H.R., et al. Surgery increases survival in patients with gastrinoma. Ann Surg 2006, 244:410-419.
74. Ellison E.C., Sparks J., Verducci J.S., et al. 50 year appraisal of gastrinoma: recommendations for staging and treatment. J Am Coll Surg 2006, 202:897-905.
75. Que F.G., Nagorney D.M., Batts K.P., et al. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995, 169:36-42.
76. Norton J.A., Warren R.S., Kelly M.G., et al. Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 2003, 134:1057-1063.
77. Becker S.W., Kahn D. Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syph 1942, 45:169.
78. Wermers R.A., Fatourechi V., Kvols L.K. Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors. Mayo Clin Proc 1996, 71:1030.
79. Verner J.V., Morrison A.B. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 1958, 25:374-380.
80. Ghaferi A.A., Chojnacki K.A., Long W.D., et al. Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg 2008, 12:382-393.
81. Ganda O.P., Weir G.C., Soeldner J.S., et al. Somatostatinoma: a somatostatin-containing tumor of the endocrine pancreas. N Engl J Med 1977, 296:963-967.
82. Nesi G., Marcucci T., Rubio C.A., et al. Somatostatinoma: clinicopathological features of three cases and literature reviewed. Gastroenterology 2007, 23:521-526.
83. Phan G.Q., Yeo C.J., Hruban R.H., et al. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 1998, 2:472-482.
84. Solarzano C.C., Lee J.E., Pisters P.W., et al. Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 2001, 130:1078-1085.
85. Frantz V.K. Tumors of the pancreas. Atlas of tumor pathology 1959, 32-33. US Armed Forces Institute of Pathology, Washington, DC. 1st series. C.W. Blumberg (Ed.).
86. Kloppel G., Socia E., Longnecker D.S., et al. Histological typing of tumors of the exocrine pancreas, International histological classification of tumours 1996, Springer Verlag, World Health Organization, New York, p. 15-21. 2nd edition.
87. Martin R.C., Klimstra D.S., Brennan M.F., et al. Solid pseudopapillary tumor of the pancreas: a surgical enigma?. Ann Surg Oncol 2002, 9:35-40.
88. Lam K.Y., Lo C.Y., Fan S.T. Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg 1999, 23:1045-1050.
89. Chen S.Q., Zou S.Q., Dai Q.B., et al. Clinical analysis of solid-pseudopapillary tumor of the pancreas: report of 15 cases. Hepatobiliary Pancreat Dis Int 2008, 7:196-200.
90. Tang L.H., Hakan A., Brennan M.F., et al. Clinically aggressive solid pseudopapillary tumors of the pancreas. Am J Surg Pathol 2005, 29:512-519.
91. Yang F., Jin C., Long J., et al. Solid pseudopapillary tumor of the pancreas: a case series of 26 consecutive patients. Am J Surg 2009, 198:210-215.
92. Nakagohri T., Kinoshita T., Konishi M., et al. Surgical outcome of solid pseudopapillary tumor of the pancreas. J Hepatobiliary Pancreat Surg 2008, 15:318-321.
93. Dong D.J., Zhang S.Z. Solid-pseudopapillary tumor of the pancreas: CT and MRI features of 3 cases. Hepatobiliary Pancreat Dis Int 2006, 5:300-304.
94. Adams A.L., Siegal G.P., Jhala N.C. Solid pseudopapillary tumor of the pancreas: a review of salient clinical and pathologic features. Adv Anat Pathol 2008, 15:39-45.
95. Abraham S.C., Klimstra D.S., Wilentz R.E., et al. Solid pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol 2000, 160:1361-1369.
96. Tanaka Y., Kato K., Notohara K., et al. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid pseudopapillary neoplasm. Cancer Res 2001, 61:8401-8404.
97. Sclafani L.M., Reuter V.E., Coit D.G., et al. The malignant nature of papillary and cystic neoplasm of the pancreas. Cancer 1991, 68:153-158.
98. Nishihara K., Nagoshi M., Tsuneyoshi M., et al. Papillary cystic tumors of the pancreas, assessment of their malignant potential. Cancer 1993, 71:82-92.
99. Salvia R., Bassi C., Festa L., et al. Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. J Surg Oncol 2007, 95:304-310.
100. Sarles H., Sarles J.C., Muratore R., et al. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease?. Am J Dig Dis 1961, 6:688-698.
101. Yoshida K., Toki F., Takeuchi T., et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995, 40:1561-1568.
102. Okazaki K., Kawa S., Kamisawa T., et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006, 21:395-397.
103. Chari S.T. Diagnosis of autoimmune pancreatitis using its five cardinal features introducing the Mayo clinic's HISORTt criteria. J Gastroenterol 2007, 42(S18):39-41.
104. Okazaki K., Chiba T. Autoimmune related pancreatitis. Gut 2002, 51:1-4.
105. Okazaki K. Autoimmune pancreatitis: etiology, pathogenesis, clinical findings and treatment. The Japanese experience. JOP 2005, 6S1:132-137.
106. Ectors N., Maillet B., Aerts R., et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997, 41:263-268.
107. Shimosegawa T., Kanno A. Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol 2009, 44:503-517.
108. Sahani D.V., Kalva S.P., Farrell J., et al. Autoimmune pancreatitis: imaging features. Radiology 2004, 233:345-352.
109. Chang W.I., Kim G.B., Lee K.J., et al. The clinical and radiological characteristics of focal mass-forming autoimmune pancreatitis. Pancreas 2009, 38:401-408.
110. Hoki N., Mizuno N., Sawaki A., et al. Diagnosis of autoimmune pancreatitis using endoscopic ultrasonography. J Gastroenterol 2009, 44:154-159.
111. Horiuchi A., Kawa S., Hamano H., et al. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002, 55:494-499.
112. Hamano H., Kawa S., Horiuchi A., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344:732-738.
113. Hochwald S.N., Hemming A.W., Draganov P., et al. Elevation of serum IgG4 in Western patients with autoimmune sclerosing pancreatocholangitis: a word of caution. Ann Surg Oncol 2008, 15:1147-1154.
114. Morselli-Labate A.M., Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-analysis. J Gastroenterol Hepatol 2009, 24:15-36.
115. Ghazale A., Chari S.T., Smyrk T.C., et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007, 102:1646-1653.
116. Kawaguchi K., Koike M., Tsuruta K., et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991, 22:387-395.
117. Deshpande V., Chicano S., Finkelberg D., et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 2007, 30:1537-1545.
118. Zhang L., Notohara K., Levy M.J., et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007, 20:23-28.
119. Kloppel G., Luttges J., Lohr M., et al. Autoimmune pancreatitis: pathological, clinical, and immunologic features. Pancreas 2003, 27:14-19.
120. Kamisawa T., Okamoto A. Autoimmune pancreatitis; proposal of IgG4 related sclerosing disease. J Gastroenterol 2006, 41:613-625.
121. Hirano K., Tada M., Isayama H., et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007, 56:1719-1724.
122. Uchida K., Yazumi S., Nishio A., et al. Long-term outcome of autoimmune pancreatitis. J Gastroenterol 2009, 44:726-732.
123. Gardner T.B., Levy M.J., Takahashi N., et al. Misdiagnosis of autoimmune pancreatitis: a caution to clinicians. Am J Gastroenterol 2009, 104:1620-1623.
124. Reddy S., Wolfgang S. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol 2009, 10:287-293.
125. Reddy S., Edil B.H., Cameron J.L. Pancreatic resection of isolated metastases from nonpancreatic primary cancers. Ann Surg Oncol 2008, 15:3199-3206.